BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 10329207)

  • 1. The nitric oxide donors, SNAP and DEA/NO, exert a negative inotropic effect in rat cardiomyocytes which is independent of cyclic GMP elevation.
    Sandirasegarane L; Diamond J
    J Mol Cell Cardiol; 1999 Apr; 31(4):799-808. PubMed ID: 10329207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y; Karmazyn M
    Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac mitochondrial cGMP stimulates cytochrome c release.
    Seya K; Motomura S; Furukawa K
    Clin Sci (Lond); 2007 Jan; 112(2):113-21. PubMed ID: 16961461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis toxin-sensitive G protein but not NO/cGMP pathway mediates the negative inotropic effect of carbachol in adult rat cardiomyocytes.
    Sandirasegarane L; Diamond J
    Pharmacology; 2004 Jan; 70(1):46-56. PubMed ID: 14646356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes.
    Wegener JW; Closs EI; Förstermann U; Nawrath H
    Br J Pharmacol; 1999 Jun; 127(3):693-700. PubMed ID: 10401560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation.
    Tseng CM; Tabrizi-Fard MA; Fung HL
    J Pharmacol Exp Ther; 2000 Feb; 292(2):737-42. PubMed ID: 10640313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that spontaneous contractile activity in the rat myometrium is not inhibited by NO-mediated increases in tissue levels of cyclic GMP.
    Hennan JK; Diamond J
    Br J Pharmacol; 1998 Mar; 123(5):959-67. PubMed ID: 9535026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
    Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
    Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of the nitric oxide-cGMP pathway exacerbates postischaemic heart injury in stroke-prone hypertensive rats.
    Itoh T; Haruna M; Abe K
    Exp Physiol; 2007 Jan; 92(1):147-59. PubMed ID: 17030559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
    Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
    Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
    Fedele E; Jin Y; Varnier G; Raiteri M
    Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of relaxation to levcromakalim by S-nitroso-N-acetylpenicillamine (SNAP) and 8-bromo cyclic GMP in the rat isolated mesenteric artery.
    White R; Hiley CR
    Br J Pharmacol; 1998 Jul; 124(6):1219-26. PubMed ID: 9720794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cyclic guanylate monophosphate in nitric oxide-induced injury to rat small intestinal epithelial cells.
    Tepperman BL; Abrahamson TD; Soper BD
    J Pharmacol Exp Ther; 1998 Mar; 284(3):929-33. PubMed ID: 9495851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual actions of dephostatin on the nitric oxide/cGMP-signalling pathway in porcine iliac arteries.
    Persson AA; Gunnarsson P; Lindström E; Grenegård M
    Eur J Pharmacol; 2005 Oct; 521(1-3):124-32. PubMed ID: 16182278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incubation of porcine iris-ciliary bodies to study the mechanisms by which nitric oxide donors lower intraocular pressure.
    Kotikoski H; Kankuri E; Vapaatalo H
    Med Sci Monit; 2003 Jan; 9(1):BR1-7. PubMed ID: 12552230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NO/cGMP pathway activation and membrane potential depolarization in pig ciliary epithelium.
    Fleischhauer JC; Bény JL; Flammer J; Haefliger IO
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1759-63. PubMed ID: 10845596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of nitric oxide synthase augments the positive inotropic effect of nitric oxide donors in the rat heart.
    Müller-Strahl G; Kottenberg K; Zimmer HG; Noack E; Kojda G
    J Physiol; 2000 Jan; 522 Pt 2(Pt 2):311-20. PubMed ID: 10639106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nitric oxide donors on cardiac contractility in wild-type and myoglobin-deficient mice.
    Wegener JW; Gödecke A; Schrader J; Nawrath H
    Br J Pharmacol; 2002 Jun; 136(3):415-20. PubMed ID: 12023944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
    Davidov T; Weiss HR; Tse J; Scholz PM
    Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide mediates interactions between GABAA receptors and adenosine A1 receptors in the rat hippocampus.
    Fragata IR; Ribeiro JA; Sebastião AM
    Eur J Pharmacol; 2006 Aug; 543(1-3):32-9. PubMed ID: 16831416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.